BROWN ADVISORY INC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 200 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
BROWN ADVISORY INC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$203,000
-31.9%
4,395
-18.9%
0.00%
Q2 2021$298,000
+6.4%
5,4200.0%0.00%
Q1 2021$280,000
+19.7%
5,4200.0%0.00%
Q4 2020$234,000
-19.6%
5,420
-0.3%
0.00%
-100.0%
Q2 2020$291,000
+42.0%
5,439
-5.9%
0.00%0.0%
Q1 2020$205,000
-37.9%
5,779
-16.3%
0.00%0.0%
Q4 2019$330,000
-97.2%
6,904
-98.1%
0.00%
-97.0%
Q3 2019$11,866,000
-33.8%
366,234
+2.0%
0.03%
-35.3%
Q2 2019$17,918,000
-29.0%
359,227
-4.0%
0.05%
-29.2%
Q1 2019$25,221,000
+57.4%
374,009
+7.6%
0.07%
+33.3%
Q4 2018$16,024,000
-39.6%
347,513
+1.1%
0.05%
-28.0%
Q3 2018$26,513,000
+1.2%
343,777
+10.5%
0.08%
-7.4%
Q2 2018$26,194,000
+4.6%
310,978
+1.6%
0.08%0.0%
Q1 2018$25,039,000
+43.8%
306,165
+0.5%
0.08%
+47.3%
Q4 2017$17,411,000
-10.4%
304,525
+4.6%
0.06%
-14.1%
Q3 2017$19,433,000
+40.7%
291,139
+8.5%
0.06%
+52.4%
Q2 2017$13,809,000
-10.3%
268,403
+1.8%
0.04%
-19.2%
Q1 2017$15,391,000
+203.9%
263,542
+117.2%
0.05%
+188.9%
Q4 2016$5,064,000121,3610.02%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
BB BIOTECH AG 2,719,998$155,502,0004.38%
Casdin Capital, LLC 295,000$16,865,0004.11%
Opaleye Management Inc. 130,000$7,432,0002.38%
Opus Point Partners Management, LLC 28,704$1,641,0001.42%
Fernwood Investment Management, LLC 27,550$1,575,0000.84%
Rhenman & Partners Asset Management AB 100,000$5,717,0000.77%
COLUMBIA WANGER ASSET MANAGEMENT LLC 760,116$43,456,0000.65%
Eventide Asset Management 214,000$12,234,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 262,984$15,035,0000.59%
CAPITAL GUARDIAN TRUST CO 663,089$37,909,0000.54%
View complete list of AGIOS PHARMACEUTICALS INC shareholders